Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Gyre Therapeutics (GYRE) Short term Debt (2016)

Gyre Therapeutics (GYRE) has disclosed Short term Debt for 7 consecutive years, with $28000.0 as the latest value for Q3 2016.

  • Quarterly Short term Debt fell 95.86% to $28000.0 in Q3 2016 from the year-ago period, while the trailing twelve-month figure was $28000.0 through Sep 2016, down 95.86% year-over-year, with the annual reading at $1.2 million for FY2015, N/A changed from the prior year.
  • Short term Debt for Q3 2016 was $28000.0 at Gyre Therapeutics, down from $130000.0 in the prior quarter.
  • The five-year high for Short term Debt was $1.2 million in Q4 2015, with the low at $28000.0 in Q3 2016.
  • Average Short term Debt over 5 years is $679800.0, with a median of $844000.0 recorded in 2012.
  • The sharpest move saw Short term Debt surged 41.42% in 2015, then plummeted 95.86% in 2016.
  • Over 5 years, Short term Debt stood at $851000.0 in 2012, then rose by 2.59% to $873000.0 in 2013, then tumbled by 45.25% to $478000.0 in 2014, then surged by 141.84% to $1.2 million in 2015, then tumbled by 97.58% to $28000.0 in 2016.
  • According to Business Quant data, Short term Debt over the past three periods came in at $28000.0, $130000.0, and $196000.0 for Q3 2016, Q2 2016, and Q1 2016 respectively.